company background image
PRN logo

Profound Medical TSX:PRN Stock Report

Last Price

CA$10.68

Market Cap

CA$263.7m

7D

-0.5%

1Y

-21.5%

Updated

04 Oct, 2024

Data

Company Financials +

PRN Stock Overview

Operates as a commercial-stage medical device company that develops and markets incision-free therapeutic systems for the image guided ablation of diseased tissue in Canada, Germany, the United States, and Finland.

PRN fundamental analysis
Snowflake Score
Valuation0/6
Future Growth2/6
Past Performance0/6
Financial Health6/6
Dividends0/6

Profound Medical Corp. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Profound Medical
Historical stock prices
Current Share PriceCA$10.68
52 Week HighCA$16.00
52 Week LowCA$9.55
Beta0.80
11 Month Change-7.53%
3 Month Change-10.18%
1 Year Change-21.47%
33 Year Change-39.86%
5 Year Change24.19%
Change since IPO-28.80%

Recent News & Updates

Recent updates

Does Profound Medical (TSE:PRN) Have A Healthy Balance Sheet?

May 03
Does Profound Medical (TSE:PRN) Have A Healthy Balance Sheet?

Is Profound Medical (TSE:PRN) Using Debt In A Risky Way?

Sep 15
Is Profound Medical (TSE:PRN) Using Debt In A Risky Way?

Will Profound Medical (TSE:PRN) Spend Its Cash Wisely?

Sep 07
Will Profound Medical (TSE:PRN) Spend Its Cash Wisely?

Here's Why We're Not Too Worried About Profound Medical's (TSE:PRN) Cash Burn Situation

Jan 07
Here's Why We're Not Too Worried About Profound Medical's (TSE:PRN) Cash Burn Situation

We Think Profound Medical (TSE:PRN) Can Easily Afford To Drive Business Growth

Jul 02
We Think Profound Medical (TSE:PRN) Can Easily Afford To Drive Business Growth

We Take A Look At Why Profound Medical Corp.'s (TSE:PRN) CEO Compensation Is Well Earned

May 13
We Take A Look At Why Profound Medical Corp.'s (TSE:PRN) CEO Compensation Is Well Earned

Analysts Expect Breakeven For Profound Medical Corp. (TSE:PRN) Before Long

May 07
Analysts Expect Breakeven For Profound Medical Corp. (TSE:PRN) Before Long

We Think Profound Medical (TSE:PRN) Can Afford To Drive Business Growth

Mar 25
We Think Profound Medical (TSE:PRN) Can Afford To Drive Business Growth

Shareholder Returns

PRNCA Medical EquipmentCA Market
7D-0.5%0.3%0.6%
1Y-21.5%-11.3%23.3%

Return vs Industry: PRN underperformed the Canadian Medical Equipment industry which returned -9.7% over the past year.

Return vs Market: PRN underperformed the Canadian Market which returned 23.4% over the past year.

Price Volatility

Is PRN's price volatile compared to industry and market?
PRN volatility
PRN Average Weekly Movement6.7%
Medical Equipment Industry Average Movement10.5%
Market Average Movement8.3%
10% most volatile stocks in CA Market17.2%
10% least volatile stocks in CA Market3.1%

Stable Share Price: PRN has not had significant price volatility in the past 3 months compared to the Canadian market.

Volatility Over Time: PRN's weekly volatility (7%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
n/a131Arun Menawatwww.profoundmedical.com

Profound Medical Corp., together with its subsidiaries, operates as a commercial-stage medical device company that develops and markets incision-free therapeutic systems for the image guided ablation of diseased tissue in Canada, Germany, the United States, and Finland. Its lead product TULSA-PRO system combines magnetic resonance imaging(MRI), robotically-driven transurethral sweeping action/thermal ultrasound and closed-loop temperature feedback control to provide precise, flexible, and durable ablation of a surgeon defined region of prostate and protect the urethra and rectum. The company also offers Sonalleve, which combines real-time MRI and thermometry for the treatment of uterine fibroids, adenomyotic tissue, palliative pain treatment of bone metastases, osteoid osteoma, and management of benign tumors.

Profound Medical Corp. Fundamentals Summary

How do Profound Medical's earnings and revenue compare to its market cap?
PRN fundamental statistics
Market capCA$263.67m
Earnings (TTM)-CA$37.45m
Revenue (TTM)CA$10.70m

24.4x

P/S Ratio

-7.0x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
PRN income statement (TTM)
RevenueUS$7.88m
Cost of RevenueUS$3.05m
Gross ProfitUS$4.83m
Other ExpensesUS$32.42m
Earnings-US$27.59m

Last Reported Earnings

Jun 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)-1.13
Gross Margin61.24%
Net Profit Margin-350.14%
Debt/Equity Ratio15.2%

How did PRN perform over the long term?

See historical performance and comparison